OnBioVC

Your Source for BioScience Venture Capital Data
Lijit Search

  • OnBioVC NEWS:

    - OnBioVC Announces Beta Launch of Service
    - OnBioVC INDEX(TM) Updated thru JUN 2010
    - OnBioVC 2Q10 Trend Analysis, now available
    - OnBioVC 3Q10 Trend Analysis, coming soon

  • SEARCH THE OnBioVC DATABASE:

  • investment bank middle market venture capital

17

Mar

2010

Syndax Pharmaceuticals, Inc.: Series A $9M

Posted in I - Series A, Q - 1Q10, R - NORTH EAST, X - HDAC, X - Oncology, XX - MA

Syndax Pharmaceuticals (Waltham, MA) a clinical-stage pharmaceutical company focused on an HDAC inhibitor for solid tumors and hematological tumors, closed a $9M Series A financing, bringing the total round to $49M. Participants include Domain Associates, MPM Capital, Avalon Ventures, Forward Ventures and Pappas Ventures.

16

Mar

2010

Syndax Pharmaceuticals, Inc.: Series A $9M

Posted in I - Series A, Q - 1Q10, R - NORTH EAST, X - HDAC, X - Oncology, XX - MA

Syndax Pharmaceuticals (Waltham, MA) a clinical-stage pharmaceutical company focused on an HDAC inhibitor for solid tumors and hematological tumors, closed a $9M Series A financing, bringing the total round to $49M. Participants include Domain Associates, MPM Capital, Avalon Ventures, Forward Ventures and Pappas Ventures.

16

Oct

2009

Acetylon Pharmaceuticals, Inc.: Series A $7.2M

Posted in I - Series A, Q - 3Q09, R - NORTH EAST, X - HDAC, X - Inflammation, X - Oncology, XX - MA

Acetylon Pharmaceuticals (Cambridge, MA) a development-stage small molecule company focused on Histone deacetylase inhibitors for oncology and inflammation indications, closed a $7.2M Series A financing. Participants may include Kraft Group Private Equity.

  

to top of page...


 

© 2009 OnBioVC An Indicium Data, LLC Company powered by WordPress